3020B |
Methylphenidate and Metabolite, Blood |
3020SP |
Methylphenidate and Metabolite, Serum/Plasma |
3020TI |
Methylphenidate and Metabolite, Tissue |
3020U |
Methylphenidate and Metabolite, Urine |
3045B |
Modafinil / Armodafinil, Blood |
3045SP |
Modafinil / Armodafinil, Serum/Plasma |
3059B |
Mitotane, Blood |
3059SP |
Mitotane, Serum/Plasma |
3124SP |
1-Naphthol, Serum/Plasma |
3150B |
Nicotine and Metabolite, Blood |
3150FL |
Nicotine and Metabolite, Fluid |
3150SP |
Nicotine and Metabolite, Serum/Plasma |
3150TI |
Nicotine and Metabolite, Tissue |
3150U |
Nicotine and Metabolite with Anabasine, Urine |
3243B |
Organochlorine Pesticides, Blood |
3243F |
Organochlorine Pesticides, Fat |
3243SP |
Organochlorine Pesticides, Serum/Plasma |
3243TI |
Organochlorine Pesticides, Tissue |
3384U |
Pentachlorophenol, Urine |
3385B |
Pentachlorophenol, Blood |
3385SP |
Pentachlorophenol, Serum/Plasma |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |